new concerns about the safety of Meridia (sibutramine)

April 2002

There are new concerns about the safety of Meridia (sibutramine).

Italy is suspending sales...a consumer group in the U.S. is asking the FDA to take Meridia off the market.

All this stems from reports of serious cardiovascular effects...MIs, strokes, arrhythmias, and some deaths.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote